These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15753771)

  • 1. Should high mobility group box-1 protein (HMGB1) be measured in patients with severe sepsis and septic shock? If so, when, where, and how?
    Eriksson M
    Crit Care Med; 2005 Mar; 33(3):682-3. PubMed ID: 15753771
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock.
    Sundén-Cullberg J; Norrby-Teglund A; Rouhiainen A; Rauvala H; Herman G; Tracey KJ; Lee ML; Andersson J; Tokics L; Treutiger CJ
    Crit Care Med; 2005 Mar; 33(3):564-73. PubMed ID: 15753748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between Single Nucleotide Polymorphisms of High Mobility Group Box 1 Protein and Clinical Outcomes in Korean Sepsis Patients.
    Lee K; Chang Y; Song K; Park YY; Huh JW; Hong SB; Lim CM; Koh Y
    Yonsei Med J; 2016 Jan; 57(1):111-7. PubMed ID: 26632390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1 in the immunology of sepsis (not septic shock) and arthritis.
    Czura CJ; Yang H; Amella CA; Tracey KJ
    Adv Immunol; 2004; 84():181-200. PubMed ID: 15246253
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence of antibodies endowed with proteolytic activity against High-mobility group box 1 protein (HMGB1) in patients surviving septic shock.
    Barnay-Verdier S; Borde C; Fattoum L; Wootla B; Lacroix-Desmazes S; Kaveri S; Gibot S; Maréchal V
    Cell Immunol; 2020 Jan; 347():104020. PubMed ID: 31767118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive Effects of Ginsenoside Rh1 on HMGB1-Mediated Septic Responses.
    Lee W; Cho SH; Kim JE; Lee C; Lee JH; Baek MC; Song GY; Bae JS
    Am J Chin Med; 2019; 47(1):119-133. PubMed ID: 30630344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
    Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
    J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of Integrin CD11b Affords Protection against Endotoxin Shock and Polymicrobial Sepsis via Attenuation of HMGB1 Nucleocytoplasmic Translocation and Extracellular Release.
    Zhou H; Li Y; Gui H; Zhao H; Wu M; Li G; Li Y; Bai Z; Yin Z; Redmond HP; Wang J; Wang JH; Zhao Z
    J Immunol; 2018 Mar; 200(5):1771-1780. PubMed ID: 29343555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontline Science: HMGB1 induces neutrophil dysfunction in experimental sepsis and in patients who survive septic shock.
    Grégoire M; Tadié JM; Uhel F; Gacouin A; Piau C; Bone N; Le Tulzo Y; Abraham E; Tarte K; Zmijewski JW
    J Leukoc Biol; 2017 Jun; 101(6):1281-1287. PubMed ID: 27965385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Analysis of Chromatin-Delivered Biomarkers in the Monitoring of Sepsis and Septic Shock: A Pilot Study.
    Beltrán-García J; Manclús JJ; García-López EM; Carbonell N; Ferreres J; Rodríguez-Gimillo M; Garcés C; Pallardó FV; García-Giménez JL; Montoya Á; Romá-Mateo C
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes.
    Stevens NE; Chapman MJ; Fraser CK; Kuchel TR; Hayball JD; Diener KR
    Sci Rep; 2017 Jul; 7(1):5850. PubMed ID: 28724977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid unites disparate syndromes of sepsis.
    Wang H; Czura CJ; Tracey KJ
    Nat Med; 2004 Feb; 10(2):124-5. PubMed ID: 14760415
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic and local high mobility group box 1 concentrations during severe infection.
    van Zoelen MA; Laterre PF; van Veen SQ; van Till JW; Wittebole X; Bresser P; Tanck MW; Dugernier T; Ishizaka A; Boermeester MA; van der Poll T
    Crit Care Med; 2007 Dec; 35(12):2799-804. PubMed ID: 17901841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of high mobility group box 1 in inflammatory disease: focus on sepsis.
    Bae JS
    Arch Pharm Res; 2012 Sep; 35(9):1511-23. PubMed ID: 23054707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of HMGB1 in apoptosis-mediated sepsis lethality.
    Qin S; Wang H; Yuan R; Li H; Ochani M; Ochani K; Rosas-Ballina M; Czura CJ; Huston JM; Miller E; Lin X; Sherry B; Kumar A; Larosa G; Newman W; Tracey KJ; Yang H
    J Exp Med; 2006 Jul; 203(7):1637-42. PubMed ID: 16818669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock.
    Barnay-Verdier S; Fattoum L; Borde C; Kaveri S; Gibot S; Maréchal V
    Intensive Care Med; 2011 Jun; 37(6):957-62. PubMed ID: 21359606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1 as a late mediator of lethal systemic inflammation.
    Wang H; Yang H; Czura CJ; Sama AE; Tracey KJ
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1768-73. PubMed ID: 11734424
    [No Abstract]   [Full Text] [Related]  

  • 18. Zingerone reduces HMGB1-mediated septic responses and improves survival in septic mice.
    Lee W; Ku SK; Bae JS
    Toxicol Appl Pharmacol; 2017 Aug; 329():202-211. PubMed ID: 28610995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of Niupo Zhibao Pellet on high-mobility group box-1 protein expression in lung tissues of endotoxin shock rats].
    Li H; Du SH; Zhang SX; Deng RD; Li C; Li YW; Chen DF; Zhou JH
    Zhong Xi Yi Jie He Xue Bao; 2009 May; 7(5):441-6. PubMed ID: 19435558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute eosinophils count as a marker of mortality in patients with severe sepsis and septic shock in an intensive care unit.
    Merino CA; Martínez FT; Cardemil F; Rodríguez JR
    J Crit Care; 2012 Aug; 27(4):394-9. PubMed ID: 22176807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.